Eurasian Cancer Research Council, a active private not for profit company, was established on 21 July 2017 in Chembur, Maharashtra, India. Engaging in oncology clinics & cancer treatment within the hospital and medical care sector, it holds CIN: U85200MH2017NPL297682. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Vasave Ulhas Jayant (Director), Dilip Jiva Gavit (Director). Past directors included Somasundaram Subramanian. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No. 10 Geetanjali 8Th Road, Near Diamod Garden, Chembur, Maharashtra, 400071.
U85200MH2017NPL297682
297682
21 July 2017
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Eurasian Cancer Research Council — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vasave Ulhas Jayant | Director | 21 Jul 2017 | Current |
| Dilip Jiva Gavit | Director | 21 Jul 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 08 Jun 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Eurasian Cancer Research Council, for the financial year ended 2023, experienced significant growth in revenue, with a 11.23% increase. The company also saw a substantial fall in profitability, with a 79.29% decrease in profit. The company's net worth observed a substantial decline by a decrease of 22.99%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Eurasian Cancer Research Council had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Eurasian Cancer Research Council, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Eurasian Cancer Research Council, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eurasian Cancer Research Council's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Eurasian Cancer Research Council last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Eurasian Cancer Research Council has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
The activity Vasave Ulhas Jayant was appointed as a Director was appointed as a Director on 21 Jul 2017 & has been associated with this company since 8 years 4 months . was completed.
The activity Dilip Jiva Gavit was appointed as a Director was appointed as a Director on 21 Jul 2017 & has been associated with this company since 8 years 4 months . was completed.
Progress on Eurasian Cancer Research Council was registered on 21 Jul 2017 with Roc Mumbai & aged 8 years 4 months as per MCA records. was documented.
The CIN of Eurasian Cancer Research Council is U85200MH2017NPL297682.
Eurasian Cancer Research Council is headquartered at Flat No. 10 Geetanjali 8Th Road, Near Diamod Garden, Chembur, Maharashtra, 400071.
Eurasian Cancer Research Council was incorporated on 21 July 2017.
The current directors of Eurasian Cancer Research Council are
The primary industry of Eurasian Cancer Research Council is Hospital And Medical Care.
Eurasian Cancer Research Council is unlisted.
The authorized capital of Eurasian Cancer Research Council is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Eurasian Cancer Research Council is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX